Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.59 +1.29 (+1.12%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,685,895
Open 115.33
Bid (Size) 115.21 (1)
Ask (Size) 116.50 (3)
Prev. Close 115.30
Today's Range 114.69 - 117.25
52wk Range 92.43 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.75%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024. 
Via Investor's Business Daily
2 Dividend Kings That Would Have Doubled Your Money in 5 Years
You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends. 
Via The Motley Fool

Performance

YTD
+6.14%
+6.14%
1 Month
+0.84%
+0.84%
3 Month
+8.15%
+8.15%
6 Month
+11.28%
+11.28%
1 Year
+24.07%
+24.07%

More News

Read More
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
Analyst Ratings For Abbott Laboratories
Via Benzinga
What You Missed On Wall Street This Past Friday
Via Talk Markets
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
Via Investor's Business Daily
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
Is Abbott Laboratories Stock a Buy?
Via The Motley Fool
AbbVie’s Dividend Isn’t As Scary As It Looks
Via Talk Markets
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Via MarketBeat
Exposures COVID-19
3 Dividend Growth Stocks You Can Buy and Hold Forever
Via The Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
Price Over Earnings Overview: Abbott Laboratories
Via Benzinga
MarketBeat Week in Review – 10/14 - 10/18
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Via The Motley Fool
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
Via Benzinga
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
Via Benzinga
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Via Benzinga
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why Abbott Laboratories Stock Was a Winner on Wednesday
Via The Motley Fool
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.